VHT News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

VH

Volume

245.65K

Loading chart

VH

VHTVanguard Health Care ETF

VHT

Pay with—

Available Balance0.00

VH

AUM

N/A

Volume

245.65K

Yield

1.18%

Chart Earnings News About Dividends Insider Filings

Better Healthcare ETF: Vanguard's Broad VHT vs. the iShares Biotechnology-Focused IBBThe article compares two healthcare ETFs: Vanguard Health Care ETF (VHT) offers broad sector exposure with a low 0.09% expense ratio and 1.4% dividend yield, while iShares Biotechnology ETF (IBB) focuses on biotech with higher growth potential (49.8% 1-year return) but greater volatility and a 39.8% maximum drawdown. VHT is recommended for conservative investors seeking stability, while IBB suits high-risk growth investors.The Motley Fool · Oct 5, 2026

3 of the Best ETFs to Buy and Hold if a Recession Is ComingThe article recommends three ETFs as defensive investments during an anticipated recession: Vanguard Healthcare ETF (VHT) for exposure to non-cyclical healthcare stocks, Vanguard Total Bond Market ETF (BND) to benefit from expected interest rate cuts, and Vanguard S&P 500 ETF (VOO) for long-term growth despite near-term volatility. Historical data shows the S&P 500 has delivered 10% annual returns despite recessions, suggesting buy-and-hold strategies outperform panic selling.The Motley Fool · Oct 2, 2026

Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPHVanguard's VHT and State Street's XPH offer different approaches to healthcare investing. VHT provides broad sector exposure with lower costs (0.09% expense ratio) and higher dividend yield (1.5%), making it ideal for long-term investors. XPH focuses on pharmaceuticals with higher volatility but stronger 1-year returns (57.2% vs 29.3%), appealing to growth-oriented investors willing to accept greater risk.The Motley Fool · Sep 10, 2026

3 Healthcare Funds to Play Safe as Consumer Sentiment Hits a LowRising oil prices due to U.S.-Iran tensions and weak consumer sentiment are creating market uncertainty. With inflation concerns and economic slowdown signals, three healthcare mutual funds are recommended as defensive investments: Vanguard Health Care Fund, Janus Henderson Global Life Sciences D, and Fidelity Select Health Care, all offering solid historical returns and low expense ratios.Zacks Investment Research · Sep 10, 2026

Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)?The ALPS Medical Breakthroughs ETF (SBIO) is a passively managed healthcare ETF that tracks small-cap and mid-cap pharmaceutical and biotechnology stocks in Phase II or Phase III FDA clinical trials. With a 0.5% expense ratio, $243.54 million in assets, and 107 holdings, it has delivered 32.1% year-to-date returns and 82.83% over 12 months. However, it carries high risk with a beta of 0.74 and 30.54% standard deviation. The fund received a Zacks ETF Rank of 3 (Hold), with alternatives like VHT and XLV offering lower expense ratios.Zacks Investment Research · Sep 8, 2026

Vanguard Health Care ETF vs Simplify Health Care ETFVanguard Health Care ETF (VHT) offers broad healthcare exposure with a low 0.09% expense ratio and 1.5% dividend yield, while Simplify Health Care ETF (PINK) provides active management with higher 1-year returns (32.4% vs 29.3%) but charges 0.51% in fees. The author recommends Simplify despite Vanguard's better year-to-date performance, citing Simplify's superior longer-term returns and its pro bono model donating profits to breast cancer research.The Motley Fool · Sep 1, 2026

Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?RSPH, an equal-weight healthcare ETF launched in 2006, has gained 17.92% year-to-date and 29.15% over the past year as of August 31, 2026. With $826.52 million in assets and a 0.40% expense ratio, it offers diversified exposure to 63 healthcare holdings. However, cheaper alternatives like VHT (0.09% expense ratio) and XLV (0.08% expense ratio) may be more suitable for cost-conscious investors seeking lower-risk options.Zacks Investment Research · Aug 31, 2026

Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?The article compares two healthcare sector ETFs: Vanguard Health Care ETF (VHT) with 423 holdings and State Street Health Care Select Sector SPDR ETF (XLV) with 60 holdings. While XLV has slightly lower expenses (0.08% vs 0.09%) and better 5-year returns, VHT outperforms on 1-year returns and offers broader diversification. The analysis recommends VHT for long-term investors due to superior recent performance and lower concentration risk.The Motley Fool · Aug 8, 2026

VHT vs. PBE: Which Health Care ETF Is the Better Buy?The Vanguard Health Care ETF (VHT) offers broad healthcare exposure with a low 0.09% expense ratio and 423 holdings, while the Invesco Biotechnology & Genome ETF (PBE) provides focused biotech exposure with 31 holdings and higher growth potential. PBE delivered a stronger 40.88% one-year return but experienced greater volatility with a 37.84% maximum drawdown, while VHT returned 27.85% with lower risk. VHT suits conservative investors seeking steady, low-cost exposure, while PBE appeals to risk-tolerant investors chasing biotech innovation.The Motley Fool · Jul 30, 2026

Vanguard Health Care ETF Outperforms VanEck Biotech on Returns, Yield, and FeesVanguard Health Care ETF (VHT) outperforms VanEck Biotech ETF (BBH) with lower fees (0.09% vs 0.35%), higher dividend yield (1.6% vs 0.5%), and superior 5-year returns ($1,278 vs $1,004 on $1,000 invested). VHT offers broad diversification across 411 healthcare holdings, while BBH provides concentrated biotech exposure with 25 stocks and higher volatility.The Motley Fool · Jul 28, 2026

to start trading

VH

VHTVanguard Health Care ETF

VHT

Pay with—

Available Balance0.00

Your PositionYou don't own any VHT yet.

Related Tickers

Earnings

Dividends

Last · Sep 23Quarterly

Amount$0.97

Yield1.41%

Annual$4.62